Home > Qtrly Results > NEULAND LABORATORIES

NEULAND LABORATORIES
Quarterly Results Analysis [Jun2026]

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹642 Cr ₹776 Cr ₹440 Cr ₹514 Cr ₹293 Cr ₹328 Cr ₹398 Cr ₹311 Cr
Expenses ₹419 Cr ₹469 Cr ₹363 Cr ₹359 Cr ₹258 Cr ₹277 Cr ₹311 Cr ₹249 Cr
Operating Income ₹223 Cr ₹307 Cr ₹77 Cr ₹156 Cr ₹34 Cr ₹51 Cr ₹87 Cr ₹62 Cr
Other Income ₹8 Cr ₹12 Cr ₹8 Cr ₹2 Cr ₹8 Cr ₹7 Cr ₹4 Cr ₹4 Cr
Interest ₹7 Cr ₹7 Cr ₹7 Cr ₹5 Cr ₹5 Cr ₹2 Cr ₹2 Cr ₹1 Cr
Depreciation ₹27 Cr ₹25 Cr ₹24 Cr ₹23 Cr ₹20 Cr ₹17 Cr ₹16 Cr ₹16 Cr
Profit Before Tax ₹198 Cr ₹287 Cr ₹54 Cr ₹129 Cr ₹18 Cr ₹39 Cr ₹128 Cr ₹49 Cr
Profit After Tax ₹148 Cr ₹213 Cr ₹41 Cr ₹97 Cr ₹14 Cr ₹28 Cr ₹102 Cr ₹33 Cr
EPS ₹114.48 ₹164.86 ₹31.45 ₹75.07 ₹10.78 ₹21.56 ₹78.75 ₹25.46
Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES 5% 24.2% 80.9%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -1.3% 21.5%
DIVIS LABORATORIES 2.7% 16.1% 38.6%
TORRENT PHARMACEUTICALS -1.5% -3.3% 35.6%
CIPLA -0.7% 1.4% -2%
DR REDDYS LABORATORIES 3.9% -1.8% 0.4%
MANKIND PHARMA -0.7% -4.9% -4.9%
LUPIN -1.8% -10.6% 16.2%
ZYDUS LIFESCIENCES 1.7% -1.2% 24.1%

NEULAND LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-17.35 %

Y-o-Y

119.15 %

Quarters Revenues % Change
Jun2026 ₹642 Cr
-17.35
Mar2026 ₹776 Cr
76.54
Dec2025 ₹440 Cr
-14.50
Sep2025 ₹514 Cr
75.67
Jun2025 ₹293 Cr
-10.84
Mar2025 ₹328 Cr
-17.50
Dec2024 ₹398 Cr
28.05
Sep2024 ₹311 Cr -

NEULAND LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-27.48 %

Y-o-Y

546.26 %

Quarters Operating Profit % Change
Jun2026 ₹223 Cr
-27.48
Mar2026 ₹307 Cr
298.44
Dec2025 ₹77 Cr
-50.41
Sep2025 ₹156 Cr
351.00
Jun2025 ₹34 Cr
-32.47
Mar2025 ₹51 Cr
-41.02
Dec2024 ₹87 Cr
39.16
Sep2024 ₹62 Cr -
Operating Margins
Q-o-Q

-12.25 %

Y-o-Y

194.91 %

Quarters Operating Margin% % Change
Jun2026 34.74%
-12.25
Mar2026 39.59%
125.71
Dec2025 17.54%
-42.02
Sep2025 30.25%
156.79
Jun2025 11.78%
-24.24
Mar2025 15.55%
-28.54
Dec2024 21.76%
8.69
Sep2024 20.02% -

NEULAND LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-30.56 %

Y-o-Y

962.47 %

Quarters Profit After Tax % Change
Jun2026 ₹148 Cr
-30.56
Mar2026 ₹213 Cr
424.17
Dec2025 ₹41 Cr
-58.11
Sep2025 ₹97 Cr
596.85
Jun2025 ₹14 Cr
-50.01
Mar2025 ₹28 Cr
-72.63
Dec2024 ₹102 Cr
209.31
Sep2024 ₹33 Cr -
PAT Margins
Q-o-Q

-15.99 %

Y-o-Y

384.63 %

Quarters PAT Margin(%) % Change
Jun2026 23.02 %
-15.99
Mar2026 27.4 %
196.86
Dec2025 9.23 %
-50.98
Sep2025 18.83 %
296.42
Jun2025 4.75 %
-43.92
Mar2025 8.47 %
-66.81
Dec2024 25.52 %
141.44
Sep2024 10.57 % -

NEULAND LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-30.56 %

Y-o-Y

961.97 %

Quarters EPS % Change
Jun2026 ₹114.48
-30.56
Mar2026 ₹164.86
424.20
Dec2025 ₹31.45
-58.11
Sep2025 ₹75.07
596.38
Jun2025 ₹10.78
-50.00
Mar2025 ₹21.56
-72.62
Dec2024 ₹78.75
209.31
Sep2024 ₹25.46 -

You may also like the below Video Courses